Why is Titan Biotech falling/rising?

As of 17-Sep, Titan Biotech Ltd's stock price is rising, currently at Rs 894.90, reflecting an increase of Rs 42.6 or 5.0%. The stock has shown strong performance recently, gaining 32.73% over the last seven days and outperforming its sector by 4.01% today. It opened with a gain of 4.94% and reached an intraday high of Rs 894.90. Over the past week, the stock has delivered a remarkable return of 26.37%, significantly higher than the Sensex's 1.56% increase. The company has a low debt-to-equity ratio of 0.05, indicating financial stability, and has consistently generated returns, outperforming the BSE500 over the last three years. However, it faces challenges with a declining operating profit growth rate of -3.08% over the last five years and a significant drop in profits by -12.3% despite the positive stock performance.
Broader market context shows that Titan Biotech's recent returns are substantially higher than the benchmark, with a 1-week return of 26.37% compared to the Sensex's 1.56%. This strong performance is indicative of investor confidence, likely driven by the company's consistent returns and liquidity, as evidenced by rising delivery volumes. However, the lack of domestic mutual fund investment may signal caution among institutional investors regarding the stock's valuation, which is considered expensive relative to its peers. Overall, while the stock is currently rising, the mixed signals from its financial performance and market perception suggest a complex outlook for future growth.